Sputnik V

On Request For Sputnik 5 Vaccine Approval, Panel Seeks More Data: Sources

India News | Reported by Sukirti Dwivedi, Edited by Shylaja Varma | Thursday February 25, 2021

The Subject Expert Committee (SEC) of the Indian drug regulator has asked pharma giant Dr Reddy's Laboratories, the Indian manufacturer of Sputnik V, the Russia-developed coronavirus vaccine, for more data regarding its application for emergency use approval for the vaccine, sources said.

Sputnik 5, Efficacy 91.6%, For India? Meeting Today To Review

India News | Reported by Sukirti Dwivedi, Edited by Shylaja Varma | Wednesday February 24, 2021

The Subject Expert Committee (SEC) of the Indian drug regulator will meet today to take up an application by pharma giant Dr Reddy's Laboratories seeking emergency approval for Sputnik V, the Russia-developed coronavirus vaccine. The vaccine has an efficacy of 91.6 per cent.

Dr Reddy's Starts Process For Emergency Use Authorisation Of Covid-19 Vaccine Sputnik V

Business | Edited by Nirmalya Sen | Friday February 19, 2021

Dr Reddy's will present the safety profile of phase two study and interim data of phase three study which is expected to completed by February 21

Dr Reddy's Initiates Process For Emergency Use Authorisation Of Sputnik V

India News | ANI | Friday February 19, 2021

Dr Reddy's Laboratories said on Friday it has initiated the process with the Drugs Controller General of India (DCGI) for emergency use authorisation of human adenoviral vector-based platform vaccine candidate Sputnik V.

Iran Starts Covid Vaccination Campaign With Russia's Sputnik V Vaccine

World News | Agence France-Presse | Tuesday February 9, 2021

Iran began its Covid-19 vaccination campaign on Tuesday using Russia's Sputnik V jab to fight the Middle East's deadliest outbreak of the illness.

Brazil Aims To Buy 30 Million COVID-19 Vaccine Doses From Russia, India

World News | Agence France-Presse | Thursday February 4, 2021

The Brazilian government announced Wednesday it was negotiating the purchase of 30 million coronavirus vaccine doses from Russia and India, after regulators made it easier for the treatments to win emergency-use authorizations.

Russia Expects India To Approve Sputnik V Vaccine For Use Soon: Report

India News | Reuters | Wednesday February 3, 2021

India is expected to grant emergency use authorization for Russia's Sputnik V COVID-19 vaccine this month or next, the Russian Direct Investment Fund (RDIF), which markets the shot abroad, told ANI on Tuesday.

Russia's Sputnik V Vaccine 91.6% Effective In Late-Stage Trial: Lancet

World News | Agence France-Presse | Tuesday February 2, 2021

Russia's Sputnik V vaccine is 91.6 percent effective against symptomatic Covid-19, according to results published in The Lancet on Tuesday that independent experts said allayed transparency concerns over the jab, which Moscow is already rolling out.

Dr Reddy's Aims To Launch Russia's Sputnik V Vaccine For Emergency Use In March

India News | Press Trust of India | Friday January 29, 2021

Dr Reddy's Laboratories, which is conducting Phase 3 trials of Russia's COVID-19 vaccine Sputnik V, believes the jab is expected to be launched in India through Emergency Use Authorisation, a senior official of the city-based drug maker said on Friday.

Iran Approves Russia's Sputnik V Covid Vaccine

World News | Agence France-Presse | Tuesday January 26, 2021

Iran has approved Russia's Sputnik V coronavirus vaccine, Foreign Minister Mohammad Javad Zarif said on Tuesday, in a win for Moscow as it aims to bolster its geopolitical clout.

Russian Covid Vaccine In Phase 3 Trial, To Cost Less Than $10 Per Dose In India

India News | ANI | Friday January 22, 2021

The Russian COVID-19 vaccine "Sputnik V" will cost less than USD 10 (about Rs 730) per shot in India and the price is the same for all countries, Kirill Dmitriev, CEO of Russian Direct Investment Fund (RDIF) said on Thursday.

Sputnik V COVID-19 Vaccine Safe In India Mid-Stage Trial: Dr Reddy's

India News | Reuters | Tuesday January 12, 2021

Dr Reddy's Laboratories Ltd said on Monday an independent board found Russia's Sputnik V COVID-19 vaccine to be safe in its mid-stage trial in India, and recommended progressing to late-stage trials.

Russia To Trial "Light" One-Dose Version Of Sputnik Jab

World News | Agence France-Presse | Tuesday January 12, 2021

Russia will trial a one-dose version of its Sputnik V coronavirus vaccine, officials said on Monday, as they aim to provide a stopgap solution for badly hit countries.

Dr.Reddy's Says Sputnik V Covid-19 Vaccine Safe In India Mid-stage Trial

Business | Edited by Nirmalya Sen | Monday January 11, 2021

The company has submitted the mid-stage trial safety data to India's drug regulator for review and approval to continue late-stage trials

1.5 Million People Vaccinated Globally With Sputnik V: Russia

World News | Agence France-Presse | Monday January 11, 2021

Russia announced Monday that 1.5 million people around the world had received its Sputnik V coronavirus vaccine as part of an initiative Kremlin critics have described as a geopolitical push.